Pharmaceuticals

IPCA Laboratories Limited

Who owns IPCA Laboratories Limited?

The promoter group held 44.72% of Ipca at 30 September 2026, led by Kaygee Investments Private Limited (25.49%). Public shareholders held 55.28%.3 Filed categories do not identify every ultimate beneficial owner.

What the company does

Manufactures formulations and active pharmaceutical ingredients for India and export markets.

Official website
www.ipca.com
Headquarters
Mumbai, Maharashtra (registered office city)
Registered office
48, Kandivli Industrial Estate, Kandivli (West), Mumbai, 400067, Maharashtra, India Address source
Country of incorporation
India
Corporate Identity Number
L24239MH1949PLC0078372
Incorporated
1949 · Public limited company
LEI
33580069PZ8ZQVCDBC386
Exchange identifiers
NSE IPCALAB · BSE 524494 · ISIN INE571A010382
Exchange listing dates
NSE 1995-02-087 · BSE 1994-05-062 (IPO offer price not verified in this release)
Largest reported categoryAs of 2026-09-30
55.28%
Public shareholders

A shareholder category in this filed snapshot; it is not an individual beneficial owner.

Explore disclosed holdings
Disclosure as of
CoverageAggregate shareholder categories
Indexed entries2

What the disclosure establishes

Filed categories are not individual beneficial owners. Promoter and public categories do not, by themselves, establish ultimate economic ownership or voting control. Named holders below are subsets of those categories.

Scope. Shareholding pattern dated 30 September 2026. A = promoter group; B = public; C2 = employee trusts. Percentages use the (A+B+C2) denominator. Categories are not identified people and are not evidence of ultimate beneficial control.

Ownership composition

Aggregate shareholder categories; not individual beneficial owners.

Promoter and promoter group 44.72%Public shareholders 55.28%

Aggregate categories in this record

3 categories

Shareholder categoryReported holdingSource
Promoter and promoter group44.72%Original disclosure
Public shareholders55.28%Original disclosure
Shares held by employee trusts (C2)0.00% reported as zeroOriginal disclosure

Named shareholders in the filing

16 named

Names exactly as filed in Table II (promoter group) and Table III (public holders above 1%). They are part of the categories above; do not add them to the category totals.

Name as filedFiling tableHolding
Kaygee Investments Private LimitedPromoter group (Table II) · Any Other (specify)25.49%4
Kaygee Laboratories Private LimitedPromoter group (Table II) · Any Other (specify)6.61%4
Chandurkar Investments Private LimitedPromoter group (Table II) · Any Other (specify)5.50%4
Premchand GodhaPromoter group (Table II) · Individuals/Hindu undivided Family2.29%4
Usha M ChandurkarPromoter group (Table II) · Individuals/Hindu undivided Family1.70%4
Usha Premchand GodhaPromoter group (Table II) · Individuals/Hindu undivided Family0.95%4
Sameer M ChandurkarPromoter group (Table II) · Individuals/Hindu undivided Family0.79%4
Pranay GodhaPromoter group (Table II) · Individuals/Hindu undivided Family0.67%4
HDFC MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds9.51%4
KOTAK MAHINDRA MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds6.34%4
DSP MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds4.12%4
SBI LIFE INSURANCE CO. LTDPublic, above 1% (Table III) · Insurance Companies3.53%4
NIPPON INDIA MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds2.72%4
AXIS MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds2.04%4
EDELWEISS TRUSTEESHIP CO LTDPublic, above 1% (Table III) · Mutual Funds1.21%4
HSBC MUTUAL FUNDPublic, above 1% (Table III) · Mutual Funds1.13%4

3 further promoter-group members with smaller holdings are listed in the original filing.4

Inside the public category

Table III sub-totals

Sub-categoryHolding
Domestic institutions (B1)36.59%
Foreign institutions, incl. FPIs (B2)11.53%
Central and state governments (B3)0.00%
Non-institutional shareholders (B4)7.15%

Sub-totals of the 55.28% public category in the same filing.4

Dated disclosures in the Atlas

2 observations

As ofPromoter (A)Public (B)Employee trusts (C2)
44.72%55.28%0.00%3
44.72%55.28%0.00%8

Data, history and downloads

Machine-readable record

From → toPromoterPublicEmployee trusts
2026-06-30 → 2026-09-300.00 pp0.00 pp0.00 pp

Differences between the filed category percentages of consecutive dated disclosures, in percentage points. Earlier disclosures are kept unchanged.

Original exchange disclosures are linked above and remain the authoritative record. The files below are The Raisina Post’s compilation of them: JSON · CSV · Markdown. Last modified 2026-10-13. See the dataset method and limitations.

Verified shareholders named in this record: SBI Life Insurance Co. Ltd..

Compare with other companies in Pharmaceuticals.

Original filing and record context

Original source
NSE XBRL shareholding pattern (SEBI LODR Reg. 31) for IPCALAB · 30 September 2026 · Table I summary
Observation date
2026-09-30
Filed with the exchange
2026-10-13
Verification
Category totals match in the BSE and NSE copies of this filing
Disclosure type
Aggregate categories, with named holders shown separately
Atlas entity ID
RPA-000294
Atlas verification date
2026-11-22

Percentages are copied from the filing without recalculation and use the (A+B+C2) denominator. Compare the original document before using these figures for investment, procurement or governance decisions.

References

  1. Official company website (as listed in the BSE company record)
  2. BSE company record: registered office, CIN, ISIN, industry
  3. NSE XBRL filing: shareholding pattern dated 30 September 2026, Table I
  4. BSE shareholding pattern: Tables II and III (named holders)
  5. NSE shareholding-pattern filing index for IPCALAB
  6. GLEIF LEI record
  7. NSE equity master list (listing date)
  8. Shareholding pattern dated 30 June 2026

Questions about this company

From the dated Atlas record and official sources.